✦ LIBER ✦

PCN14 COST-EFFECTIVENESS OFTAXANES AS SECOND LINE AGENTS IN TREATMENT OF METASTATIC BREAST CANCER

✍ Scribed by AA Kawatkar; JW Hay

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN22 COST-EFFECTIVENESS OF SUNITINIBAS

✍ F Van Nooten; S Dewilde; S Van Belle; S Marbaix 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN101 Cost Effectiveness of Everolimus

✍ J. Mihajlović; P. Pechlivanoglou; A. Sabo; Z. Tomić; M.J. Postma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Single-agent gemcitabine as second- and

✍ T. Brodowicz; W.J. Kostler; R. Möslinger; S. Tomek; I. Vaclavik; V. Herscovici; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Single-agent gemcitabine as second- and

✍ W.J. Köstler; T. Brodowicz; R. Möslinger; S. Tomek; I. Vaclavik; V. Herscovici; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 170 KB

PCN23 COST-EFFECTIVENESS ANALYSIS OF LAP

✍ F Ejzykowicz; JW Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCN15 COST-EFFECTIVENESS OF NEW TARGETED

✍ EC Aiello; N Muszbek; E Richardet; A Lingua; C Charbonneau; E Remák 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB